His primary areas of study are Breast cancer, Surgery, Internal medicine, Mastectomy and Oncology. His Breast cancer study improves the overall literature in Cancer. His Cancer research integrates issues from Chemotherapy and Pathology.
His research in Surgery intersects with topics in Carcinoma, Radiology, Mammary gland and Clinical trial. His Mastectomy research is multidisciplinary, incorporating perspectives in Breast reconstruction, Survival rate, Retrospective cohort study, Stage and Prospective cohort study. His Oncology research includes elements of Inflammatory breast cancer, Total Mastectomy, Proportional hazards model and Adjuvant therapy.
The scientist’s investigation covers issues in Breast cancer, Internal medicine, Oncology, Surgery and Mastectomy. His research investigates the connection between Breast cancer and topics such as Radiology that intersect with problems in Mammography. Axillary lymph nodes, Metastasis and Lymph is closely connected to Lymph node in his research, which is encompassed under the umbrella topic of Oncology.
His work in Surgery tackles topics such as Carcinoma which are related to areas like Breast carcinoma. His Mastectomy study combines topics in areas such as Breast reconstruction, Breast surgery, Retrospective cohort study and Survival rate. The concepts of his Cancer study are interwoven with issues in Gynecology and Pathology.
His primary scientific interests are in Breast cancer, Internal medicine, Oncology, Mastectomy and Surgery. His Breast cancer study is concerned with Cancer in general. His research on Oncology also deals with topics like
Henry Mark Kuerer interconnects Breast reconstruction, Ductal carcinoma, Breast surgery and Stage in the investigation of issues within Mastectomy. His Surgery research is multidisciplinary, incorporating elements of Breast-conserving surgery and Total Mastectomy. His work carried out in the field of Radiology brings together such families of science as Sentinel lymph node, Axillary Dissection and Axilla.
His main research concerns Breast cancer, Surgery, Mastectomy, Internal medicine and Cancer. He works mostly in the field of Breast cancer, limiting it down to topics relating to Radiology and, in certain cases, Cohort, as a part of the same area of interest. Henry Mark Kuerer is involved in the study of Surgery that focuses on Surgical oncology in particular.
His Mastectomy research is multidisciplinary, incorporating perspectives in Survival rate, Breast surgery, Carcinoma and Radiation therapy. His research on Internal medicine frequently connects to adjacent areas such as Oncology. His research integrates issues of Guideline, Uncertain significance and Disease in his study of Cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
Henry M. Kuerer;Lisa A. Newman;Terry L. Smith;Fred C. Ames.
Journal of Clinical Oncology (1999)
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
W. Fraser Symmans;Florentia Peintinger;Christos Hatzis;Radhika Rajan.
Journal of Clinical Oncology (2007)
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial
Judy C. Boughey;Vera J. Suman;Elizabeth A. Mittendorf;Gretchen M. Ahrendt.
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection
Abigail S. Caudle;Wei T. Yang;Savitri Krishnamurthy;Elizabeth A. Mittendorf.
Journal of Clinical Oncology (2016)
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Anthony Lucci;Carolyn S Hall;Ashutosh K. Lodhi;Anirban Bhattacharyya.
Lancet Oncology (2012)
Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.
Y. Xing;M. Foy;D. D. Cox;H. M. Kuerer.
British Journal of Surgery (2006)
Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.
Roman Rouzier;Radhika Rajan;Peter Wagner;Kenneth R. Hess.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero
Karin M.E. Hahn;Peter H. Johnson;Nancy Gordon;Henry Kuerer.
Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform
Kevin R. Coombes;Spiridon Tsavachidis;Jeffrey Morris;Keith A Baggerly.
Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy
Bryan T. Hennessy;Gabriel N. Hortobagyi;Roman Rouzier;Henry Kuerer.
Journal of Clinical Oncology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: